INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
06/10/2026
Back to search
Official data from USPTO
RECIPHARM PATHWAY TO CLINIC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RECIPHARM PATHWAY TO CLINIC
ST13
US500000079230420Class
42
Filing
79230420
Registration
5705937
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
06/11/2026
Trademark type
Word
Nice classes
42
Filing date
08/28/2017
Registration date
03/26/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/10/2025
Last transaction
06/11/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
SE
Examiner
NELMAN, JESSE M
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Recipharm AB (publ)
Representatives
M. Scott Alprin Alprin Law Offices, P.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical drug development services; product research and development; conducting clinical tests and trials for others; technical project management for others relating to all the aforesaid services
Publications
History of USPTO decisions and trademark events.
28 publications found
C71T
CANCELLED SECTION 71
10/10/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/26/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/16/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/31/2019
FIMP
FINAL DISPOSITION PROCESSED
07/31/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/26/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
03/26/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/08/2019
PUBO
PUBLISHED FOR OPPOSITION
01/08/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/19/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/16/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/27/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/26/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/26/2018
RFNP
REFUSAL PROCESSED BY IB
05/25/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/04/2018
RFRR
REFUSAL PROCESSED BY MPU
05/04/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/01/2018
CNRT
NON-FINAL ACTION WRITTEN
04/30/2018
MAFR
APPLICATION FILING RECEIPT MAILED
04/27/2018
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
04/26/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/24/2018
CNRT
NON-FINAL ACTION WRITTEN
04/23/2018
DOCK
ASSIGNED TO EXAMINER
04/23/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/23/2018
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
04/20/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/19/2018
Continuous trademark protection
Get notified about every new filing that threatens RECIPHARM PATHWAY TO CLINIC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.